Literature DB >> 18566320

State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary.

Steven K Grinspoon, Carl Grunfeld, Donald P Kotler, Judith S Currier, Jens D Lundgren, Michael P Dubé, Steven E Lipshultz, Priscilla Y Hsue, Kathleen Squires, Morris Schambelan, Peter W F Wilson, Kevin E Yarasheski, Colleen M Hadigan, James H Stein, Robert H Eckel.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18566320      PMCID： PMC3642216          DOI： 10.1161/CIRCULATIONAHA.107.189622

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  61 in total

1.  Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy.

Authors:  Marc van der Valk; Miriam Casula; Gerrit-Jan Weverlingz; Kees van Kuijk; Berthe van Eck-Smit; Hendrick-Jan Hulsebosch; Pythia Nieuwkerk; Arne van Eeden; Kees Brinkman; Joep Lange; Anthony de Ronde; Peter Reiss
Journal:  Antivir Ther       Date:  2004-06

2.  Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Judith A Aberg; Joel E Gallant; Jean Anderson; James M Oleske; Howard Libman; Judith S Currier; Valerie E Stone; Jonathan E Kaplan
Journal:  Clin Infect Dis       Date:  2004-08-11       Impact factor: 9.079

3.  Screening for coronary heart disease: recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2004-04-06       Impact factor: 25.391

Review 4.  Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group.

Authors:  Michael P Dubé; James H Stein; Judith A Aberg; Carl J Fichtenbaum; John G Gerber; Karen T Tashima; W Keith Henry; Judith S Currier; Dennis Sprecher; Marshall J Glesby
Journal:  Clin Infect Dis       Date:  2003-08-15       Impact factor: 9.079

5.  Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study.

Authors:  Naveed Sattar; Ken Williams; Allan D Sniderman; Ralph D'Agostino; Steven M Haffner
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

6.  Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitors.

Authors:  James H Stein; Michelle A Merwood; Jennifer L Bellehumeur; Susan E Aeschlimann; Claudia E Korcarz; Gail L Underbakke; Maureen E Mays; James M Sosman
Journal:  Am Heart J       Date:  2004-04       Impact factor: 4.749

Review 7.  HIV-related cardiovascular disease and drug interactions.

Authors:  Kinjal A Nanavati; Stacy D Fisher; Tracie L Miller; Steven E Lipshultz
Journal:  Am J Cardiovasc Drugs       Date:  2004       Impact factor: 3.571

8.  Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial.

Authors:  Colleen Hadigan; Sigal Yawetz; Abraham Thomas; Fiona Havers; Paul E Sax; Steven Grinspoon
Journal:  Ann Intern Med       Date:  2004-05-18       Impact factor: 25.391

9.  Vascular endothelial toxicity induced by HIV protease inhibitor: evidence of oxidant-related dysfunction and apoptosis.

Authors:  Reshma S Baliga; Cynthia Liu; Dale G Hoyt; Alysia A Chaves; John A Bauer
Journal:  Cardiovasc Toxicol       Date:  2004       Impact factor: 3.231

10.  Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection.

Authors:  Priscilla Y Hsue; Joan C Lo; Arlana Franklin; Ann F Bolger; Jeffrey N Martin; Steven G Deeks; David D Waters
Journal:  Circulation       Date:  2004-03-15       Impact factor: 29.690
View more
  78 in total

1.  Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1.

Authors:  Tracie L Miller; Gabriel Somarriba; E John Orav; Armando J Mendez; Daniela Neri; Natasha Schaefer; Lourdes Forster; Ronald Goldberg; Gwendolyn B Scott; Steven E Lipshultz
Journal:  J Acquir Immune Defic Syndr       Date:  2010-10       Impact factor: 3.731

2.  HIV and general cardiovascular risk.

Authors:  Bernadette Capili; Joyce K Anastasi; Olugbenga Ogedegbe
Journal:  J Assoc Nurses AIDS Care       Date:  2011-02-01       Impact factor: 1.354

3.  Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons.

Authors:  Andy I Choi; Eric Vittinghoff; Steven G Deeks; Cristin C Weekley; Yongmei Li; Michael G Shlipak
Journal:  AIDS       Date:  2011-06-19       Impact factor: 4.177

4.  Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection.

Authors:  Emily S Ford; Jamieson H Greenwald; Aaron G Richterman; Adam Rupert; Lauren Dutcher; Yunden Badralmaa; Ven Natarajan; Catherine Rehm; Colleen Hadigan; Irini Sereti
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

Review 5.  Endocrinological aspects of HIV infection.

Authors:  F S Mirza; P Luthra; L Chirch
Journal:  J Endocrinol Invest       Date:  2018-01-08       Impact factor: 4.256

Review 6.  Biomarkers and HIV-associated cardiovascular disease.

Authors:  Jason V Baker; Daniel Duprez
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

7.  Global Longitudinal Strain and Immune Status in Patients Living With Human Immunodeficiency Virus.

Authors:  Fawaz Alenezi; Gerald S Bloomfield; Nwora Lance Okeke; Poonam Velagapudi; Loai Abudaqa; Nkechinyere Ijioma; Allison Dunning; Hasan Alajmi; Meredith E Clement; Svati H Shah; Susanna Naggie; Eric J Velazquez
Journal:  Am J Cardiol       Date:  2019-06-29       Impact factor: 2.778

8.  A genome-wide association study of carotid atherosclerosis in HIV-infected men.

Authors:  Sadeep Shrestha; Marguerite R Irvin; Kent D Taylor; Howard W Wiener; Nicholas M Pajewski; Talin Haritunians; Joseph A C Delaney; Morris Schambelan; Joseph F Polak; Donna K Arnett; Yii-Der Ida Chen; Carl Grunfeld
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

9.  Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.

Authors:  Margalida Rotger; Tracy R Glass; Thomas Junier; Jens Lundgren; James D Neaton; Estella S Poloni; Angélique B van 't Wout; Rubin Lubomirov; Sara Colombo; Raquel Martinez; Andri Rauch; Huldrych F Günthard; Jacqueline Neuhaus; Deborah Wentworth; Danielle van Manen; Luuk A Gras; Hanneke Schuitemaker; Laura Albini; Carlo Torti; Lisa P Jacobson; Xiuhong Li; Lawrence A Kingsley; Federica Carli; Giovanni Guaraldi; Emily S Ford; Irini Sereti; Colleen Hadigan; Esteban Martinez; Mireia Arnedo; Lander Egaña-Gorroño; Jose M Gatell; Matthew Law; Courtney Bendall; Kathy Petoumenos; Jürgen Rockstroh; Jan-Christian Wasmuth; Kabeya Kabamba; Marc Delforge; Stephane De Wit; Florian Berger; Stefan Mauss; Mariana de Paz Sierra; Marcelo Losso; Waldo H Belloso; Maria Leyes; Antoni Campins; Annalisa Mondi; Andrea De Luca; Ignacio Bernardino; Mónica Barriuso-Iglesias; Ana Torrecilla-Rodriguez; Juan Gonzalez-Garcia; José R Arribas; Iuri Fanti; Silvia Gel; Jordi Puig; Eugenia Negredo; Mar Gutierrez; Pere Domingo; Julia Fischer; Gerd Fätkenheuer; Carlos Alonso-Villaverde; Alan Macken; James Woo; Tara McGinty; Patrick Mallon; Alexandra Mangili; Sally Skinner; Christine A Wanke; Peter Reiss; Rainer Weber; Heiner C Bucher; Jacques Fellay; Amalio Telenti; Philip E Tarr
Journal:  Clin Infect Dis       Date:  2013-03-26       Impact factor: 9.079

10.  Yoga lifestyle intervention reduces blood pressure in HIV-infected adults with cardiovascular disease risk factors.

Authors:  W T Cade; D N Reeds; K E Mondy; E T Overton; J Grassino; S Tucker; C Bopp; E Laciny; S Hubert; S Lassa-Claxton; K E Yarasheski
Journal:  HIV Med       Date:  2010-01-05       Impact factor: 3.180
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.